Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
1 - 5 of 5 search results for `Financial Economics` |u:techpolicymphil.blog.jbs.cam.ac.uk

  1. Fully-matching results

  2. https://techpolicymphil.blog.jbs.cam.ac.uk/tag/rcts/feed/

    https://techpolicymphil.blog.jbs.cam.ac.uk/tag/rcts/feed/
    22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of

  3. https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ebola/feed/

    https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ebola/feed/
    22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of

  4. https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ethics/feed/

    https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ethics/feed/
    22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of

  5. https://techpolicymphil.blog.jbs.cam.ac.uk/tag/pharma/feed/

    https://techpolicymphil.blog.jbs.cam.ac.uk/tag/pharma/feed/
    22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of

  6. https://techpolicymphil.blog.jbs.cam.ac.uk/tag/vaccines/feed/

    https://techpolicymphil.blog.jbs.cam.ac.uk/tag/vaccines/feed/
    22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of

Refine your results

clear all

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.